|
Dr. Marson is the founder and CEO of Future Sight Inc. which provides consulting services for the implementation of innovative technological solutions for scientific research and the analysis of corporate formation requirements. After an NIH Postdoctoral Fellowship at UC Berkeley, he co-founded Molecular Design Limited (MDL) in 1978. Acting as its Chairman, President and CEO, Dr. Marson helped this start-up grow into the world’s largest supplier of software for handling chemical information. In September, 1987, MDL was acquired by Maxwell Communication Corporation (MCC), went public in July of 1993 and was acquired by Elsevier Science in April, 1997. In late 1987, Dr. Marson assumed the position of Executive VP of Scientific Innovation at MCC West, reporting to Kevin Maxwell, and was given the Skolnik Award from the American Chemical Society’s Chemical Information Division for his contributions in the field of chemical information. Along with Dr. Alejandro Zaffaroni, Dr. Marson co-founded AXS in September 1989 and Digital Collections, Inc. in May of 1993, which merged to form Digital Arts & Sciences Corporation (DAS). Acting, at various times, as its Chairman, President and CEO, Dr. Marson helped DAS become a leading supplier of collections management software and now maintains a position on its Board of Directors. Dr. Marson received a B.S. and S.M. in Chemistry from MIT and a Ph.D. in Organic Chemistry from Stanford University. | 